Modified story memory technique may help cognitive rehabilitation in MS patients

NewsGuard 100/100 Score

Modified story memory technique used to treat learning and memory deficits in multiple sclerosis

John DeLuca, PhD, Vice President for Research at Kessler Foundation presented findings on the use of a behavioral technique for cognitive rehabilitation in people with multiple sclerosis (MS). Lead investigator was Nancy Chiaravalloti, PhD, director of the Neuropsychology & Neuroscience Laboratory at Kessler Foundation. The presentation on modified Story Memory Technique was made on October 21, 2011 in Amsterdam at the 5th Joint Triennial Congress of the European and Americas Committees for Treatment and Research in Multiple Sclerosis (ECTRIMS and ACTRIMS).

Two Randomized Clinical Trials (RCT) have been conducted to examine changes in neuropsychological memory measures post-treatment, one using the Hopkins Verbal Learning Test Revised and the other using the California Verbal Learning Test - II. Changes were also examined in patterns of cerebral activation on fMRI post-treatment during performance of learning and memory tasks. No baseline activation differences on fMRI were seen between groups. After treatment, greater activation was evident in the treatment group during performance of a memory task within a widespread cortical network involving frontal, parietal, precuneus, and parahippocampal regions. "These findings add to our understanding of memory processes in MS," said Dr. DeLuca, "and will help us determine effective interventions for cognitive rehabilitation. "

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New research pinpoints key pathways in prostate cancer's vulnerability to ferroptosis